New clues to cause of bile duct cancer
Scientists at the CRM have identified a molecule that drives the development of bile duct cancer. The research in mice and human cells sheds new light on what triggers the disease and how the illness progresses.
Cell Reports study
Dr Katrin Ottersbach: "Our findings reveal the first changes that take place in blood development caused by the MLL-AF4 mutation during a pre-cancerous state."
MRC funding to improve iPS technology
Dr Abdenour Soufi awarded £1.8M for novel synthetic factors to improve iPS technology.
Stem Cells Transl Med
New study shows a potential future treatment for paracetamol overdose and that stem cell derived liver cells can act as a good model of drug toxicity in the liver.